Connect your AI

Tandem Diabetes Care TNDM Inventories

Inventories at other companies

InsuletPODD

$462.5M+4.9%

MedtronicMDT

$5.95B+8.7%

AdaptHealthAHCO

$159.27M+23.2%

MannkindMNKD

$49.17M+70.2%

AbbottABT

$6.99B+5.3%

OmnicellOMCL

$99.2M+8.8%

Other financials

Income statement

Revenue$247.2M+5.5%

Gross profit$136.8M+15.5%

Operating income-$17.4M+85.6%

Net income-$20.4M+84.4%

EPS (diluted)-$0.30+84.8%

Balance sheet

Cash & equivalents$179.3M+235%

Total debt$734.7M+49.0%

Total equity$132.4M-14.7%

Total assets$1.2B+25.1%

Cash flow

Operating cash flow$11.1M+160%

CapEx$6.3M+111%

Free cash flow$4.8M+123%

Valuation

Market cap$1.03B-23.6%

Enterprise value$1.58B-11.3%

P/S1×-0.4×

Profitability

Gross margin54.9%+2.7pp

Operating margin-8.2%-2.9pp

Net margin-9.2%-3.1pp

FCF margin-0.8%-0.4pp

Returns & leverage

Return on equity-65.7%-14.7pp

Debt / equity5.5×+2.4×

Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tandem Diabetes Care's inventories?: Tandem Diabetes Care (TNDM) reported inventories of $126.4M in Q1 2026.
How has Tandem Diabetes Care's inventories changed year-over-year?: Tandem Diabetes Care's inventories decreased by 10.5% year-over-year, from $141.17M to $126.4M.
What is the long-term trend for Tandem Diabetes Care's inventories?: Over 5 years (2020 to 2025), Tandem Diabetes Care's inventories has grown at a 15.1% compound annual growth rate (CAGR), from $63.72M to $128.77M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.